SonoCiné AWBUS Technology, detecting and diagnosing breast cancer in dense-breasted women

Dr. Kevin Kelly, one of the country's leading authorities on breast cancer detection and Co-Founder of SonoCiné, Inc. joins eHealth Radio and the Cancer Prevention & Technology Channels.
Listen to interview with host Eric Michaels and guest Dr. Kevin Kelly discuss the following:

• Describe to our listeners what SonoCiné AWBUS is and what does AWBUS stand for?
• What makes SonoCiné AWBUS™ technology different?
• How does it work?
• I understand this exam is for women with dense breast tissue. What is the difference between dense-breast tissue and fatty-breast tissue?
• Recently it seems there has been states passing a law that are Dense Breast Tissue notification laws. What are those laws and how do they impact what your team is trying to do? 
• Do you see ultrasound one day replacing mammography? 
• Why has every doctor not adopted the technology yet? 
• Where can women go to get more information or to find a doctor that performs the SonoCiné exam? 

Duration: 17:05
Dr. Kevin M. Kelly is Chief Executive Officer, Chairman of the Board, Chief Medical Officer and Co-Founder of SonoCiné, Inc. He is also Medical Director of the Breast Ultrasound Center in Pasadena, CA.
Dr. Kelly is one of the country's leading authorities on breast cancer detection in women with dense-breast tissue and women with implants. He was Director of Breast Imaging at the Huntington Memorial Hospital and the Huntington Hill Breast Center, Pasadena, CA for 20 years before opening a private practice in Pasadena, CA.   His breakthrough clinical study on breast cancer detection using ultrasound in radiographically dense breasts was published in 2009 in European Radiology (one of the most prestigious radiology journals in the world).  This pivotal work has since been cited in more than 100 other scientific publications around the world.
Dr. Kelly's lifelong commitment to early breast cancer detection began with clinical research into the limitations of mammography in detecting and diagnosing breast cancer in dense-breasted women.  In 1997, he co-founded SonoCiné, Inc., to develop and clinically validate what is now known as the SonoCiné AWBUS™ technology.  Working with other leading breast imaging radiologists, more than 6,000 clinical results demonstrated a 100% increase in detection (over mammography) of invasive cancers smaller than 1cm in diameter.  With this success, he moved to launch SonoCiné, Inc.
Dr. Kelly earned his Bachelor of Science degree at Georgetown University.  He completed his Medical Degree, internship and first two years of residency at St. Louis University and the St. Louis University Service of St. Louis City Hospital.  He was the Leo G. Rigler Center Research Fellow at UCLA from 1973 to 1974 and finished his final year of residency at the Wadsworth Veterans Administration Hospital in Los Angeles.
In addition to his many professional credentials in the field of radiology, Dr. Kelly was also a Lt. Commander in the U.S. Public Health Service.

Website: www.sonocine.com